Viewbix Inc. — Form 10-Q summary
Filing identity: The supplied filing is for Viewbix Inc. (formerly Virtual Crypto Technologies, Inc.), not Quantum X Labs Inc. It covers the quarter and nine months ended September 30, 2020; statements are unaudited and financial amounts below are in U.S. dollars, thousands, except per-share data.
Business context and reporting period
Viewbix describes itself as an interactive video technology and data platform for video marketing. Its 2020 results reflect significant cost reductions announced after revenue goals were missed. The company’s cryptocurrency-focused subsidiary ceased operations and was sold in February 2020.
Financial performance and position
| Metric | Q3 2020 | Q3 2019 | Nine months 2020 | Nine months 2019 |
|---|---|---|---|---|
| Revenue | $17 | $63 | $86 | $139 |
| Gross profit | $16 | $62 | $81 | $135 |
| Operating loss | $55 | $267 | $317 | $656 |
| Net loss | $44 | $284 | $311 | $735 |
| Operating cash flow | $(14) | $(44) | $(37) | $(60) |
- Gross margin was approximately 94% for Q3 and 94% for the nine-month period, compared with approximately 98% and 97%, respectively, in the prior-year periods.
- At September 30, 2020, cash and cash equivalents were $65; current assets were $89 and current liabilities were $2,093, resulting in negative working capital of $2,004. At December 31, 2019, cash was $87, current assets were $225, current liabilities were $1,923, and negative working capital was $1,698.
- Current liabilities included $1,902 payable to parent Gix, up from $1,611 at year-end 2019. The filing does not identify interest-bearing debt separately.
- Total stockholders’ deficit was $2,004 at September 30, 2020, versus $1,693 at December 31, 2019. Shares outstanding were 31,201,669.
Changes versus prior comparable periods
Revenue fell 73% in Q3 and 38% for the first nine months year over year. Management attributed the declines to cost reductions initiated January 1, 2020. Operating expenses also fell substantially: nine-month research and development was $59 versus $170, selling and marketing was $8 versus $199, and general and administrative expense was $339 versus $422. The lower expenses reduced the nine-month net loss, although revenue contraction continued. Q3 financial results included net financial income of $11, compared with expense of $21 a year earlier; the nine-month figures were income of $8 versus expense of $60, primarily reflecting exchange-rate differences.
Outlook, risks, contingencies, and unusual items
- Going concern and financing: Management expects substantial operating losses to continue and plans to seek outside capital. The company has no committed external funding source; availability and terms are uncertain. The filing states that these conditions raise substantial doubt about the company’s ability to continue as a going concern.
- Controls: Management concluded disclosure controls and procedures were ineffective at September 30, 2020 because of material weaknesses. No material change in internal control over financial reporting during the quarter was reported.
- COVID-19: The company could not estimate the pandemic’s full effects and warned that continuing developments and mitigation measures could adversely affect its business, results, and financial condition.
- Legal matters: A shareholder dispute was settled in September 2020 through Gix’s transfer of 63,350 Gix shares; the company said the settlement had no effect on its financial statements. A former CEO’s approximately $100,000 wrongful-termination claim remained pending; management considered it without merit and recorded no provision.
- Other items: The sale of the cryptocurrency subsidiary generated a reported $8 gain and $13 cash proceeds. The filing gives no quantified revenue or earnings guidance.
Important facts for investors to verify
- Confirm the issuer and ticker: the filing identifies Viewbix Inc. (OTCQB: VBIX), not Quantum X Labs Inc.
- Assess near-term funding needs, access to capital, and the parent-company payable, given $65 of cash and $2,093 of current liabilities.
- Review the disclosed material weaknesses and any subsequent remediation or auditor-related updates.
- Track whether cost reductions can be sustained without further weakening revenue, customer acquisition, or product development.
- Check subsequent developments in the former CEO litigation and the company’s COVID-19 exposure.